GRFS

7.10

2.74% -0.20

Handel nachbörslich: 7.10

Grifols Sa Adr (GRFS)

Überblick Nachrichten Preisverlauf Optionskette Warum fällt GRFS? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$7.30

Offen:

$7.22

24-Stunden-Volumen:

1.19M

Relative Volume:

1.16

Marktkapitalisierung:

$5.00B

Einnahmen:

$7.94B

Nettoeinkommen (Verlust:

$225.54M

KGV:

21.52

EPS:

0.3299

Netto-Cashflow:

$709.16M

1W Leistung:

-3.40%

1M Leistung:

+2.45%

6M Leistung:

-25.18%

1J Leistung:

+2.31%

1-Tages-Spanne:

$7.09

$7.2769

1-Wochen-Bereich:

$7.0807

$7.49

52-Wochen-Spanne:

$5.79

$9.96

Grifols Sa Adr Stock (GRFS) Company Profile

Firmenname

Grifols Sa Adr

Sektor

Healthcare (1153)

Branche

Drug Manufacturers - General (19)

Telefon

Adresse

Mitarbeiter

23,822

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

GRFS's Discussions on Twitter

Vergleichen Sie GRFS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GRFS Grifols Sa Adr	7.10	5.00B	7.94B	225.54M	709.16M	0.3299
LLY Lilly Eli Co	734.57	739.39B	49.00B	11.11B	-1.27B	12.29
JNJ Johnson Johnson	154.22	375.64B	89.33B	21.81B	18.57B	8.99
ABBV Abbvie Inc	184.60	351.09B	57.37B	4.20B	17.83B	2.35
NVO Novo Nordisk Adr	65.77	307.32B	43.59B	15.04B	10.74B	3.3766
NVS Novartis Ag Adr	108.70	225.73B	53.22B	12.86B	14.85B	6.39

Grifols Sa Adr Stock (GRFS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-12	Fortgesetzt	Morgan Stanley	Overweight
2024-03-12	Herabstufung	Deutsche Bank	Hold → Sell
2023-04-12	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-03-03	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2023-02-16	Hochstufung	Barclays	Underweight → Equal Weight
2023-01-18	Hochstufung	Jefferies	Hold → Buy
2022-04-08	Eingeleitet	Morgan Stanley	Equal-Weight
2021-11-05	Herabstufung	Deutsche Bank	Buy → Hold
2021-10-19	Herabstufung	Barclays	Overweight → Underweight
2021-10-06	Hochstufung	Citigroup	Neutral → Buy
2021-06-14	Hochstufung	Deutsche Bank	Hold → Buy
2021-04-20	Eingeleitet	Deutsche Bank	Hold
2021-03-23	Hochstufung	Credit Suisse	Neutral → Outperform
2021-03-11	Hochstufung	HSBC Securities	Hold → Buy
2020-10-01	Hochstufung	Citigroup	Sell → Neutral
2020-06-09	Herabstufung	Citigroup	Neutral → Sell
2020-06-09	Hochstufung	HSBC Securities	Reduce → Hold
2020-03-25	Herabstufung	Citigroup	Buy → Neutral
2019-06-27	Hochstufung	JP Morgan	Neutral → Overweight
2019-02-08	Herabstufung	Berenberg	Buy → Hold
2018-10-11	Hochstufung	Berenberg	Hold → Buy
2018-06-01	Eingeleitet	Barclays	Overweight
2017-10-31	Eingeleitet	Citigroup	Buy
2017-06-30	Herabstufung	Goldman	Buy → Neutral
2017-04-06	Eingeleitet	BofA/Merrill	Buy
2017-01-03	Hochstufung	JP Morgan	Neutral → Overweight
2016-02-09	Hochstufung	Berenberg	Hold → Buy
2016-01-04	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2015-12-02	Herabstufung	HSBC Securities	Buy → Hold
2015-11-20	Herabstufung	Berenberg	Buy → Hold
2015-04-28	Herabstufung	Berenberg	Buy → Hold

Alle ansehen

Grifols Sa Adr Aktie (GRFS) Neueste Nachrichten

May 02, 2025

Grifols S.A. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire

May 02, 2025

Apr 28, 2025

SMRT’s latest rating updates from top analysts. - knoxdaily.com

Apr 28, 2025

Investing in Grifols SA ADR (GRFS): What You Must Know - knoxdaily.com

Apr 28, 2025

Investing in Apellis Pharmaceuticals Inc (APLS) Is Getting More Attractive - knoxdaily.com

Apr 28, 2025

A company insider recently sold 10,000 shares of News Corp [NWSA]. Should You also Consider to Sale? - knoxdaily.com

Apr 28, 2025

Raymond James Downgrades Truist Financial Corporation (TFC) to a Mkt perform from an Outperform - knoxdaily.com

Apr 28, 2025

AT&T, Inc (T) rating upgrades by Exane BNP Paribas - knoxdaily.com

Apr 28, 2025

Apr 25, 2025